Botox 200 Allergan jedinica, prašak za otopinu za injekciju
| Name | Botox 200 Allergan jedinica, prašak za otopinu za injekciju |
|---|---|
| Marketing Authorisation Number | HR-H-144437659 |
| Active Substance | neurotoksin Clostridium botulinum tip A (900 kDa) |
| Composition | 1 bočica s praškom za otopinu za injekciju sadrži 200 Allergan jedinica botulinskog toksina tipa A (iz bakterije Clostridium botulinum) |
| Pharmaceutical Form | prašak za otopinu za injekciju |
| Manufacturer | Allergan Pharmaceuticals Ireland, Westport, County Mayo, Irska AbbVie Deutschland GmbH & Co. KG, Ludwigshafen, Njemačka |
| Marketing Authorisation Holder | AbbVie d.o.o., Strojarska cesta 20, Zagreb, Hrvatska |
| Marketing Authorisation Date | 02.11.2022 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/19-02/189 |
| Registration Number | 381-12-01/70-22-16 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | Medicinal product subject to restricted medical prescription |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | M03AX01 |
| Marketing status | Never marketed |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
